[{"data":1,"prerenderedAt":255},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services:0":3},{"blogPost":4,"otherBlogs":85},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":30,"class_list":31,"featured_media_src_url":40,"_links":41},736,"2026-10-06T18:27:09",{"rendered":8},"https://wp.ncikenya.go.ke/?p=736","nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services","publish","post","https://wp.ncikenya.go.ke/2026/10/06/nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services/",{"rendered":14},"NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized laboratory technologies, including flow cytometry, which plays an important role in the diagnosis and management of several cancers, particularly haematological malignancies.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Key areas discussed included:\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Recognition of flow cytometry as an essential specialized cancer diagnostic service.\u003C/li>\n\n\n\n\u003Cli>Adoption of panel-based reimbursement rather than individual antibody-based reimbursement.\u003C/li>\n\n\n\n\u003Cli>Appropriate reimbursement for immunohistochemistry (IHC) panels.\u003C/li>\n\n\n\n\u003Cli>Development of national technical and quality standards for specialized cancer diagnostics.\u003C/li>\n\n\n\n\u003Cli>Establishment of coordinated specimen-referral pathways.\u003C/li>\n\n\n\n\u003Cli>Recognition of qualified reference laboratories to support testing, training and quality assurance.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The AMPATH delegation included Dr. Teresa Lotodo, Lead Pathologist and Chair, Pathology Department, Moi University & Medical Director, Flow Cytometry Laboratory; Raphael Koima, AFCP Program Manager/Coordinator; Dr. Gilbert Olbara, Lead Clinician and Head of Paediatric Oncology, MTRH; Dr. Ronald Tonui, Director, AMPATH Reference Laboratory; and Nicholas Kigen, Lead Laboratory Scientist, ARL.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting reaffirmed the importance of strategic partnerships, innovation and strengthened diagnostic capacity in improving early and accurate cancer diagnosis and ultimately advancing Kenya’s cancer response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K remains committed to building partnerships that strengthen cancer prevention, diagnosis, treatment and care towards a cancer-free nation.\u003C/p>\n",false,{"rendered":19,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor. The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized […]\u003C/p>\n",1,737,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[28,29],4,43,[],[32,11,33,34,35,36,37,38,39],"post-736","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/DSC_5500.JPG-1024x683.jpeg",{"self":42,"collection":48,"about":51,"author":54,"replies":58,"version-history":61,"predecessor-version":64,"wp:featuredmedia":68,"wp:attachment":71,"wp:term":74,"curies":81},[43],{"href":44,"targetHints":45},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736",{"allow":46},[47],"GET",[49],{"href":50},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[52],{"href":53},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[55],{"embeddable":56,"href":57},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[59],{"embeddable":56,"href":60},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=736",[62],{"count":20,"href":63},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions",[65],{"id":66,"href":67},738,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions/738",[69],{"embeddable":56,"href":70},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/737",[72],{"href":73},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=736",[75,78],{"taxonomy":76,"embeddable":56,"href":77},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=736",{"taxonomy":79,"embeddable":56,"href":80},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=736",[82],{"name":83,"href":84,"templated":56},"wp","https://api.w.org/{rel}",[86,139,197],{"id":87,"date":88,"date_gmt":88,"guid":89,"modified":88,"modified_gmt":88,"slug":91,"status":10,"type":11,"link":92,"title":93,"content":95,"excerpt":97,"author":20,"featured_media":98,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":99,"categories":101,"tags":102,"class_list":103,"featured_media_src_url":106,"_links":107},701,"2026-08-14T13:52:50",{"rendered":90},"https://wp.ncikenya.go.ke/?p=701","the-nci-k-frequently-asked-questions","https://wp.ncikenya.go.ke/2026/08/14/the-nci-k-frequently-asked-questions/",{"rendered":94},"THE NCI-K FREQUENTLY ASKED QUESTIONS",{"rendered":96,"protected":17},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of FREQUENTLY ASKED QUESTIONS.\">\u003C/object>\u003Ca id=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\">FREQUENTLY ASKED QUESTIONS\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\">Download\u003C/a>\u003C/div>\n",{"rendered":23,"protected":17},0,{"pagelayer_contact_templates":100,"_pagelayer_content":23,"footnotes":23},[],[20],[],[104,11,33,34,35,37,105],"post-701","category-uncategorized",null,{"self":108,"collection":113,"about":115,"author":117,"replies":119,"version-history":122,"predecessor-version":125,"wp:attachment":129,"wp:term":132,"curies":137},[109],{"href":110,"targetHints":111},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701",{"allow":112},[47],[114],{"href":50},[116],{"href":53},[118],{"embeddable":56,"href":57},[120],{"embeddable":56,"href":121},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=701",[123],{"count":20,"href":124},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions",[126],{"id":127,"href":128},703,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions/703",[130],{"href":131},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=701",[133,135],{"taxonomy":76,"embeddable":56,"href":134},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=701",{"taxonomy":79,"embeddable":56,"href":136},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=701",[138],{"name":83,"href":84,"templated":56},{"id":140,"date":141,"date_gmt":141,"guid":142,"modified":144,"modified_gmt":144,"slug":145,"status":10,"type":11,"link":146,"title":147,"content":149,"excerpt":151,"author":20,"featured_media":153,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":154,"categories":156,"tags":157,"class_list":158,"featured_media_src_url":160,"_links":161},675,"2026-06-17T18:12:30",{"rendered":143},"https://wp.ncikenya.go.ke/?p=675","2026-06-17T18:15:38","kukha-2026-advancing-health-innovation-through-kenya-uk-collaboration","https://wp.ncikenya.go.ke/2026/06/17/kukha-2026-advancing-health-innovation-through-kenya-uk-collaboration/",{"rendered":148},"KUKHA 2026: Advancing Health Innovation Through Kenya–UK Collaboration.",{"rendered":150,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Building a Healthier Future for Kenya and Africa\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The 4th Kenya–United Kingdom Health Alliance (KUKHA) One Health Research & Innovation Conference, taking place from 17–19 June 2026 at Jacaranda Hotel, Nairobi, brings together policymakers, researchers, healthcare professionals, academia, industry leaders, investors, and development partners to explore innovative solutions to some of the most pressing health challenges facing Kenya, Africa, and the world. Guided by the theme “From Challenges to Global Solutions Together: Building Kenya & Africa’s Health Innovation Future,” the conference serves as a platform to strengthen partnerships, share knowledge, and drive transformative action in healthcare.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-1024x683.jpg\" alt=\"\" class=\"wp-image-681\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-1024x683.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-300x200.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-768x512.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-1536x1024.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1673-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Plenary Session\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As Kenya and many African countries continue to experience a growing burden of non-communicable diseases, KUKHA 2026 places particular emphasis on cancer and kidney disease, both of which are increasing at alarming rates. Alongside these conditions, health security threats such as antimicrobial resistance (AMR) continue to challenge healthcare systems globally. Conference plenary sessions will examine the factors contributing to these trends and explore evidence-based strategies to improve prevention, diagnosis, treatment, and patient outcomes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Leading experts from Kenya and the United Kingdom will share insights on strengthening healthcare systems, improving access to quality care, and promoting sustainable interventions that can address current and future health challenges. Discussions will also focus on how international collaboration can accelerate progress and create lasting impact across the continent.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-1024x683.jpg\" alt=\"\" class=\"wp-image-676\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-1024x683.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-300x200.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-768x512.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-1536x1024.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_1607-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Participants following the proceedings at the 4th KAKHU conference\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference recognizes that resilient health systems require strong emergency preparedness and response mechanisms. Through dedicated sessions on global standards in emergency medicine and health security, participants will explore innovative approaches adopted across different healthcare systems and examine lessons applicable to Kenya and Africa.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">One of the key highlights of KUKHA 2026 is the focus on local health manufacturing and innovation. As Africa seeks greater self-reliance in healthcare products and technologies, the conference will explore opportunities for strengthening pharmaceutical production, vaccine manufacturing, medical technology development, and commercialization of health innovations. Experts from government, academia, industry, and development organizations will discuss how strategic investments, supportive policies, and partnerships can help build a thriving health manufacturing ecosystem.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Participants will also examine issues related to intellectual property, technology transfer, licensing, market shaping, and industrial parks as catalysts for economic growth and healthcare transformation. These discussions are expected to contribute to Kenya’s broader vision of becoming a regional hub for health innovation and manufacturing.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Advancing Cancer Care and Research\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Cancer remains a major public health concern in Kenya and across Africa. Dedicated cancer tracks will focus on the burden of disease, healthcare gaps, partnership opportunities, diagnostics, oncology services, prevention strategies, genomics, clinical trials, and cancer care infrastructure. Participants will discuss the importance of early diagnosis, access to quality treatment, and the role of research in improving outcomes for patients.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sessions will also examine emerging issues such as climate-informed cancer prevention, the impact of aflatoxins, and the role of genomics in developing more effective and personalized treatment approaches for African populations. Through these conversations, stakeholders hope to identify practical solutions that can reduce cancer-related mortality and strengthen cancer care systems across the region.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Promoting Universal Health Coverage\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Universal Health Coverage (UHC) remains a critical pillar of Kenya’s health agenda. KUKHA 2026 provides a platform for discussing how innovation, medical technology, digital health solutions, and strategic partnerships can support equitable access to healthcare services. Participants will explore ways to strengthen healthcare delivery systems, improve patient experiences, and ensure that quality care reaches all communities.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference will also examine the role of healthcare financing, governance, and collaboration between national and county governments in achieving sustainable UHC goals. By sharing experiences and lessons from Kenya and the United Kingdom, stakeholders aim to identify scalable solutions that can improve health outcomes nationwide.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference aims to facilitate meaningful outcomes, including new partnerships, investment commitments, collaborative projects, and pathways for strengthening Kenya–UK health cooperation. Discussions will focus on building sustainable mechanisms for accountability, follow-up, and continued engagement beyond the conference itself. As delegates gather in Nairobi, the conference provides a unique opportunity to shape the future of health innovation, foster meaningful partnerships, and advance the shared goal of healthier communities across Kenya, Africa, and the world.\u003C/p>\n",{"rendered":152,"protected":17},"\u003Cp>Building a Healthier Future for Kenya and Africa The 4th Kenya–United Kingdom Health Alliance (KUKHA) One Health Research & Innovation Conference, taking place from 17–19 June 2026 at Jacaranda Hotel, Nairobi, brings together policymakers, researchers, healthcare professionals, academia, industry leaders, investors, and development partners to explore innovative solutions to some of the most pressing health […]\u003C/p>\n",678,{"pagelayer_contact_templates":155,"_pagelayer_content":23,"footnotes":23},[],[20],[],[159,11,33,34,35,36,37,105],"post-675","https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/DSC_0534-1024x680.jpg",{"self":162,"collection":167,"about":169,"author":171,"replies":173,"version-history":176,"predecessor-version":180,"wp:featuredmedia":184,"wp:attachment":187,"wp:term":190,"curies":195},[163],{"href":164,"targetHints":165},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/675",{"allow":166},[47],[168],{"href":50},[170],{"href":53},[172],{"embeddable":56,"href":57},[174],{"embeddable":56,"href":175},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=675",[177],{"count":178,"href":179},2,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/675/revisions",[181],{"id":182,"href":183},682,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/675/revisions/682",[185],{"embeddable":56,"href":186},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/678",[188],{"href":189},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=675",[191,193],{"taxonomy":76,"embeddable":56,"href":192},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=675",{"taxonomy":79,"embeddable":56,"href":194},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=675",[196],{"name":83,"href":84,"templated":56},{"id":198,"date":199,"date_gmt":199,"guid":200,"modified":202,"modified_gmt":202,"slug":203,"status":10,"type":11,"link":204,"title":205,"content":207,"excerpt":209,"author":20,"featured_media":211,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":212,"categories":214,"tags":215,"class_list":216,"featured_media_src_url":218,"_links":219},707,"2026-09-03T04:12:11",{"rendered":201},"https://wp.ncikenya.go.ke/?p=707","2026-09-03T06:18:42","university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration","https://wp.ncikenya.go.ke/2026/09/03/university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration/",{"rendered":206},"University of Manchester Team Visits NCI-K to Explore Opportunities for Cancer Research, Training and Capacity-Building Collaboration",{"rendered":208,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visiting team was received by the \u003Cstrong>NCI-K Chief Executive Officer\u003C/strong>, Dr. Elias Melly, who highlighted the Institute’s mandate and its ongoing efforts to strengthen cancer control through research, evidence generation, innovation and strategic partnerships.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large is-resized\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"759\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg\" alt=\"\" class=\"wp-image-712\" style=\"aspect-ratio:1.349195973329847;width:563px;height:auto\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-300x222.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-767x568.jpg 767w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1536x1138.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-2048x1517.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>From left,\u003C/strong> \u003Cstrong>Professor Sacha Howell – Division of Cancer Sciences; Professor Robert Bristow\u003C/strong> – \u003Cstrong>Director, Manchester Cancer Research Centre; Dr. Elias Melly, CEO, NCI-k\u003C/strong> and \u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong>\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the visit, the delegation was briefed on the \u003Cstrong>National Cancer Registry\u003C/strong>, including cancer data collection, analysis and reporting in Kenya. The team also received a presentation on the \u003Cstrong>NCI-K Cancer Data Dashboard\u003C/strong>, showcasing the latest available \u003Cstrong>2024 cancer data\u003C/strong> and its role in informing cancer planning, policy, research and service delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation was further taken through \u003Cstrong>research projects supported by NCI-K through its Seed Grant Programme\u003C/strong>, highlighting the Institute’s commitment to promoting locally relevant research and building Kenya’s cancer research capacity.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Exploring Areas of Strategic Collaboration\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Discussions focused on areas where the complementary strengths of NCI-K and the Manchester cancer research ecosystem could support advances across the cancer care and research continuum.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A key area was \u003Cstrong>breast cancer screening and imaging\u003C/strong>, including strengthening national mammography services, improving screening uptake in rural and urban settings, and exploring the application of \u003Cstrong>artificial intelligence and machine learning in mammographic image interpretation and cancer detection\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also explored opportunities for collaboration in \u003Cstrong>lung cancer screening\u003C/strong>, with a focus on generating evidence to inform appropriate screening approaches and strengthening early detection.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Other areas identified included \u003Cstrong>histopathology and diagnostic capacity\u003C/strong>, particularly through assessing skills gaps and developing targeted approaches to strengthen specialist expertise, laboratory capacity and cancer diagnostics.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Training, Fellowships and Mentorship\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement also explored opportunities for \u003Cstrong>fellowships, mentorship and structured training programmes\u003C/strong> for Kenyan researchers and healthcare professionals. Discussions included the development of \u003Cstrong>online learning modules, short-term training programmes and other flexible professional development opportunities\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These areas align with Manchester’s established strength in cancer education, clinical research and workforce development. The Manchester Cancer Research Centre brings together \u003Cstrong>The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK\u003C/strong>, creating an integrated environment in which basic science, translational research and clinical practice are closely connected. The Centre’s research strategy spans multiple cancer types and links basic, translational and clinical research through a wider network of externally funded institutes, centres and research programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Genomics, AI and Precision Cancer Research\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions further identified opportunities for joint research in \u003Cstrong>genomics, artificial intelligence and machine learning\u003C/strong>, including the use of advanced technologies to improve cancer diagnosis, understand disease biology and support data-driven cancer research.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Manchester has significant expertise in \u003Cstrong>cancer genomics and data science\u003C/strong>, with ongoing international research programmes examining the genetic basis of cancer and opportunities to improve early detection and treatment. Importantly, Manchester already has an active research collaboration in \u003Cstrong>Kenya on oesophageal cancer\u003C/strong>, led by Professor Rob Bristow in partnership with Kenyan researchers, focusing on early detection and the genetic changes associated with oesophageal squamous cell cancer.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also discussed opportunities to explore the application of \u003Cstrong>AI in research methodologies\u003C/strong>, including innovative approaches to study design and participant randomisation.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement highlighted the potential for NCI-K and Manchester to build on complementary strengths: \u003Cstrong>NCI-K’s national cancer data, research mandate and understanding of Kenya’s cancer landscape\u003C/strong>, alongside Manchester’s expertise in \u003Cstrong>cancer genomics, precision oncology, imaging, artificial intelligence, clinical research, translational science, education and multidisciplinary cancer care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Manchester Cancer Research Centre is a world-leading comprehensive cancer research partnership, bringing together scientists, clinicians and research institutions to accelerate the translation of discoveries into improved cancer prevention, diagnosis and treatment. Its strong international outlook and existing collaborations in Kenya provide a valuable foundation for expanding research and capacity-building partnerships.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K and the University of Manchester will continue discussions to translate the areas identified into practical programmes that can contribute to \u003Cstrong>strengthening cancer research, innovation, early detection, diagnostics, workforce development and cancer control in Kenya\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>University of Manchester Delegation\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation included:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong> Rachel previously served at the Manchester Cancer Research Centre, where she led training and education and supported international links, academic collaborations, and research-related education programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Robert Bristow\u003C/strong> — \u003Cstrong>Director, Manchester Cancer Research Centre (MCRC); Director, Cancer Research UK Manchester Centre; University Professor of Cancer Studies, University of Manchester; and Senior Group Leader in Translational Oncogenomics at the Cancer Research UK Manchester Institute.\u003C/strong> Professor Bristow’s research includes cancer genomics, tumour biology, DNA damage and repair, and treatment response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Sacha Howell\u003C/strong> is a professor in the Division of Cancer Sciences at the University of Manchester and a leading breast cancer clinician-researcher. His research focuses on breast cancer treatment and prevention, breast cancer risk prediction, imaging and mammographic density, with links to research in artificial intelligence and mammographic imaging.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":210,"protected":17},"\u003Cp>The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building. The visiting team was received by the NCI-K Chief Executive Officer, Dr. Elias Melly, who highlighted the Institute’s […]\u003C/p>\n",708,{"pagelayer_contact_templates":213,"_pagelayer_content":23,"footnotes":23},[],[28,29],[],[217,11,33,34,35,36,37,38,39],"post-707","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5237-1024x683.jpg",{"self":220,"collection":225,"about":227,"author":229,"replies":231,"version-history":234,"predecessor-version":238,"wp:featuredmedia":242,"wp:attachment":245,"wp:term":248,"curies":253},[221],{"href":222,"targetHints":223},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707",{"allow":224},[47],[226],{"href":50},[228],{"href":53},[230],{"embeddable":56,"href":57},[232],{"embeddable":56,"href":233},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=707",[235],{"count":236,"href":237},7,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions",[239],{"id":240,"href":241},720,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions/720",[243],{"embeddable":56,"href":244},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/708",[246],{"href":247},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=707",[249,251],{"taxonomy":76,"embeddable":56,"href":250},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=707",{"taxonomy":79,"embeddable":56,"href":252},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=707",[254],{"name":83,"href":84,"templated":56},1792071273874]